WaldoIOrtuzarMD

Oncology • Carmel, IN

Physician

Join to view full profile

Dr. Ortuzar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ortuzar's full profile

Already have an account?

Office
13869 Kickapoo Trl
Carmel, IN 46033
Phone+1 317-433-0280

Fax+1 317-277-3238

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1993
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1989 - 1992
Pontifical Catholic University Mother and TeacherClass of 1988

Certifications & Licensure

IN State Medical License 2008 - 2025
MA State Medical License 2022 - 2024
MD State Medical License 1995 - 2001
OH State Medical License 1992 - 1994

Clinical Trials

Phase 1a Study to Evaluate Immunogenicity of ASV® Start of enrollment: 2019 May 16
Completed
Phase 1
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer Start of enrollment: 2019 Apr 01
Recruiting
Phase 1
RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer Start of enrollment: 2019 Jun 01
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

4 citations
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome.
Terese C Hammond, Marco A Purbhoo, Sapana Kadel, Jerome Ritz, Sarah Nikiforow
Nature Communications. 2024-02-06
117 citations
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizu...
Ralph Zinner, Coleman K. Obasaju, David R. Spigel, Robert W. Weaver, J. Thaddeus Beck
Journal of Thoracic Oncology. 2015-01-01
26 citations
Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer.
Waldo I. Ortuzar, Nasser H. Hanna, Eduardo J. Pennella, Guangbin Peng, Corey J. Langer
Clinical Lung Cancer. 2012-01-01